APA (7th ed.) Citation

Wilson, S., Taskila, T., Ismail, T., Stocken, D., Martin, A., Redman, V., . . . Hobbs, R. (2009). Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme. BioMed Central.

Chicago Style (17th ed.) Citation

Wilson, S., T. Taskila, T. Ismail, D. Stocken, A. Martin, V. Redman, M. Wakelam, I. Perry, and R. Hobbs. Establishing the Added Benefit of Measuring MMP9 in FOB Positive Patients as a Part of the Wolverhampton Colorectal Cancer Screening Programme. BioMed Central, 2009.

MLA (9th ed.) Citation

Wilson, S., et al. Establishing the Added Benefit of Measuring MMP9 in FOB Positive Patients as a Part of the Wolverhampton Colorectal Cancer Screening Programme. BioMed Central, 2009.